BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210527T150000
DTEND;TZID=America/Vancouver:20210527T180000
DTSTAMP:20260408T134701
CREATED:20210525T023046Z
LAST-MODIFIED:20210525T023102Z
UID:16639-1622127600-1622138400@scienceinvancouver.com
SUMMARY:SCWIST Job Fair - Women in STEM
DESCRIPTION:Meet your new employer! Get a new job! Explore new careers! \nJob fair focused on connecting Canadian employers to women and other underrepresented STEM groups. \nWe have STEM companies ranging from start-ups to well-established corporations ready to hire\, on-the-spot. Plus: HR specialists and recruiters will be present to provide one-on-one resume review! \nImmigrants\, newcomers\, academia-to-industry career transitionists and mothers returning to work are strongly encouraged to join! \nRegistration is free. \nEMPLOYER SHOWCASE\nVirtual exhibitor booths will allow you to connect directly via voice\, video\, or messaging. \nPANEL DISCUSSIONS\n(Panels will be running in parallel sessions.) \nPanel 1: Navigating your job search \nPanel 2: Career opportunities in Biotech \nRESUME CLINIC\nMeet an employment adviser or recruiter in a one-on-one session to get feedback on your resume from an employment adviser or recruiter. The session is 15 minutes long. Limited spots available\, so sign up now! \nSPEED COACHING\nWorried your career is off-track? Looking for empathetic guidance and advice? Book your free one-on-one coaching session with CoachMe. The session is 15 minutes long. Limited spots available\, so sign up now!
URL:https://scienceinvancouver.com/event/scwist-job-fair-women-in-stem/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210527T150000
DTEND;TZID=America/Vancouver:20210527T180000
DTSTAMP:20260408T134701
CREATED:20210525T023046Z
LAST-MODIFIED:20210525T023046Z
UID:26394-1622127600-1622138400@scienceinvancouver.com
SUMMARY:SCWIST Job Fair - Women in STEM
DESCRIPTION:Meet your new employer! Get a new job! Explore new careers! \nJob fair focused on connecting Canadian employers to women and other underrepresented STEM groups. \nWe have STEM companies ranging from start-ups to well-established corporations ready to hire\, on-the-spot. Plus: HR specialists and recruiters will be present to provide one-on-one resume review! \nImmigrants\, newcomers\, academia-to-industry career transitionists and mothers returning to work are strongly encouraged to join! \nRegistration is free. \nEMPLOYER SHOWCASE\nVirtual exhibitor booths will allow you to connect directly via voice\, video\, or messaging. \nPANEL DISCUSSIONS\n(Panels will be running in parallel sessions.) \nPanel 1: Navigating your job search \nPanel 2: Career opportunities in Biotech \nRESUME CLINIC\nMeet an employment adviser or recruiter in a one-on-one session to get feedback on your resume from an employment adviser or recruiter. The session is 15 minutes long. Limited spots available\, so sign up now! \nSPEED COACHING\nWorried your career is off-track? Looking for empathetic guidance and advice? Book your free one-on-one coaching session with CoachMe. The session is 15 minutes long. Limited spots available\, so sign up now!
URL:https://scienceinvancouver.com/event/scwist-job-fair-women-in-stem-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210527T150000
DTEND;TZID=America/Vancouver:20210527T180000
DTSTAMP:20260408T134701
CREATED:20210525T023046Z
LAST-MODIFIED:20210525T023046Z
UID:28009-1622127600-1622138400@scienceinvancouver.com
SUMMARY:SCWIST Job Fair - Women in STEM
DESCRIPTION:Meet your new employer! Get a new job! Explore new careers! \nJob fair focused on connecting Canadian employers to women and other underrepresented STEM groups. \nWe have STEM companies ranging from start-ups to well-established corporations ready to hire\, on-the-spot. Plus: HR specialists and recruiters will be present to provide one-on-one resume review! \nImmigrants\, newcomers\, academia-to-industry career transitionists and mothers returning to work are strongly encouraged to join! \nRegistration is free. \nEMPLOYER SHOWCASE\nVirtual exhibitor booths will allow you to connect directly via voice\, video\, or messaging. \nPANEL DISCUSSIONS\n(Panels will be running in parallel sessions.) \nPanel 1: Navigating your job search \nPanel 2: Career opportunities in Biotech \nRESUME CLINIC\nMeet an employment adviser or recruiter in a one-on-one session to get feedback on your resume from an employment adviser or recruiter. The session is 15 minutes long. Limited spots available\, so sign up now! \nSPEED COACHING\nWorried your career is off-track? Looking for empathetic guidance and advice? Book your free one-on-one coaching session with CoachMe. The session is 15 minutes long. Limited spots available\, so sign up now!
URL:https://scienceinvancouver.com/event/scwist-job-fair-women-in-stem-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210527T150000
DTEND;TZID=America/Vancouver:20210527T180000
DTSTAMP:20260408T134701
CREATED:20210525T023046Z
LAST-MODIFIED:20210525T023046Z
UID:31092-1622127600-1622138400@scienceinvancouver.com
SUMMARY:SCWIST Job Fair - Women in STEM
DESCRIPTION:Meet your new employer! Get a new job! Explore new careers! \nJob fair focused on connecting Canadian employers to women and other underrepresented STEM groups. \nWe have STEM companies ranging from start-ups to well-established corporations ready to hire\, on-the-spot. Plus: HR specialists and recruiters will be present to provide one-on-one resume review! \nImmigrants\, newcomers\, academia-to-industry career transitionists and mothers returning to work are strongly encouraged to join! \nRegistration is free. \nEMPLOYER SHOWCASE\nVirtual exhibitor booths will allow you to connect directly via voice\, video\, or messaging. \nPANEL DISCUSSIONS\n(Panels will be running in parallel sessions.) \nPanel 1: Navigating your job search \nPanel 2: Career opportunities in Biotech \nRESUME CLINIC\nMeet an employment adviser or recruiter in a one-on-one session to get feedback on your resume from an employment adviser or recruiter. The session is 15 minutes long. Limited spots available\, so sign up now! \nSPEED COACHING\nWorried your career is off-track? Looking for empathetic guidance and advice? Book your free one-on-one coaching session with CoachMe. The session is 15 minutes long. Limited spots available\, so sign up now!
URL:https://scienceinvancouver.com/event/scwist-job-fair-women-in-stem-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210527T150000
DTEND;TZID=America/Vancouver:20210527T180000
DTSTAMP:20260408T134701
CREATED:20210525T023046Z
LAST-MODIFIED:20210525T023046Z
UID:32552-1622127600-1622138400@scienceinvancouver.com
SUMMARY:SCWIST Job Fair - Women in STEM
DESCRIPTION:Meet your new employer! Get a new job! Explore new careers! \nJob fair focused on connecting Canadian employers to women and other underrepresented STEM groups. \nWe have STEM companies ranging from start-ups to well-established corporations ready to hire\, on-the-spot. Plus: HR specialists and recruiters will be present to provide one-on-one resume review! \nImmigrants\, newcomers\, academia-to-industry career transitionists and mothers returning to work are strongly encouraged to join! \nRegistration is free. \nEMPLOYER SHOWCASE\nVirtual exhibitor booths will allow you to connect directly via voice\, video\, or messaging. \nPANEL DISCUSSIONS\n(Panels will be running in parallel sessions.) \nPanel 1: Navigating your job search \nPanel 2: Career opportunities in Biotech \nRESUME CLINIC\nMeet an employment adviser or recruiter in a one-on-one session to get feedback on your resume from an employment adviser or recruiter. The session is 15 minutes long. Limited spots available\, so sign up now! \nSPEED COACHING\nWorried your career is off-track? Looking for empathetic guidance and advice? Book your free one-on-one coaching session with CoachMe. The session is 15 minutes long. Limited spots available\, so sign up now!
URL:https://scienceinvancouver.com/event/scwist-job-fair-women-in-stem-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210528T074500
DTEND;TZID=America/Vancouver:20210528T203000
DTSTAMP:20260408T134701
CREATED:20210408T181152Z
LAST-MODIFIED:20210525T024759Z
UID:15951-1622187900-1622233800@scienceinvancouver.com
SUMMARY:Pathology Day
DESCRIPTION:For this years Pathology Day event\, we are excited to be using the virtual platform Gather town https://gather.town. The Pathology Day virtual space on Gather.town will be similar to an ‘onsite’ conference\, where you can meet your colleagues\, friends\, and other attendees to strike up conversations just like you would at an in-person event. Further\, it allows attendees to view talks by visiting specific rooms\, and an interactive poster session that facilitates walking through a room\, visiting those of interest and asking questions directly to the presenter face to face. \nAll talks will be done through Zoom\, accessible through the Gather town platform or directly through provided links. Posters will need to be provided to organizers by May 24th in .jpeg or .png format. \n 
URL:https://scienceinvancouver.com/event/pathology-day/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210528T074500
DTEND;TZID=America/Vancouver:20210528T203000
DTSTAMP:20260408T134701
CREATED:20210408T181152Z
LAST-MODIFIED:20210408T181152Z
UID:26375-1622187900-1622233800@scienceinvancouver.com
SUMMARY:Pathology Day
DESCRIPTION:For this years Pathology Day event\, we are excited to be using the virtual platform Gather town https://gather.town. The Pathology Day virtual space on Gather.town will be similar to an ‘onsite’ conference\, where you can meet your colleagues\, friends\, and other attendees to strike up conversations just like you would at an in-person event. Further\, it allows attendees to view talks by visiting specific rooms\, and an interactive poster session that facilitates walking through a room\, visiting those of interest and asking questions directly to the presenter face to face. \nAll talks will be done through Zoom\, accessible through the Gather town platform or directly through provided links. Posters will need to be provided to organizers by May 24th in .jpeg or .png format. \n 
URL:https://scienceinvancouver.com/event/pathology-day-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210528T074500
DTEND;TZID=America/Vancouver:20210528T203000
DTSTAMP:20260408T134701
CREATED:20210408T181152Z
LAST-MODIFIED:20210408T181152Z
UID:27990-1622187900-1622233800@scienceinvancouver.com
SUMMARY:Pathology Day
DESCRIPTION:For this years Pathology Day event\, we are excited to be using the virtual platform Gather town https://gather.town. The Pathology Day virtual space on Gather.town will be similar to an ‘onsite’ conference\, where you can meet your colleagues\, friends\, and other attendees to strike up conversations just like you would at an in-person event. Further\, it allows attendees to view talks by visiting specific rooms\, and an interactive poster session that facilitates walking through a room\, visiting those of interest and asking questions directly to the presenter face to face. \nAll talks will be done through Zoom\, accessible through the Gather town platform or directly through provided links. Posters will need to be provided to organizers by May 24th in .jpeg or .png format. \n 
URL:https://scienceinvancouver.com/event/pathology-day-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210528T074500
DTEND;TZID=America/Vancouver:20210528T203000
DTSTAMP:20260408T134701
CREATED:20210408T181152Z
LAST-MODIFIED:20210408T181152Z
UID:31073-1622187900-1622233800@scienceinvancouver.com
SUMMARY:Pathology Day
DESCRIPTION:For this years Pathology Day event\, we are excited to be using the virtual platform Gather town https://gather.town. The Pathology Day virtual space on Gather.town will be similar to an ‘onsite’ conference\, where you can meet your colleagues\, friends\, and other attendees to strike up conversations just like you would at an in-person event. Further\, it allows attendees to view talks by visiting specific rooms\, and an interactive poster session that facilitates walking through a room\, visiting those of interest and asking questions directly to the presenter face to face. \nAll talks will be done through Zoom\, accessible through the Gather town platform or directly through provided links. Posters will need to be provided to organizers by May 24th in .jpeg or .png format. \n 
URL:https://scienceinvancouver.com/event/pathology-day-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210528T074500
DTEND;TZID=America/Vancouver:20210528T203000
DTSTAMP:20260408T134701
CREATED:20210408T181152Z
LAST-MODIFIED:20210408T181152Z
UID:32533-1622187900-1622233800@scienceinvancouver.com
SUMMARY:Pathology Day
DESCRIPTION:For this years Pathology Day event\, we are excited to be using the virtual platform Gather town https://gather.town. The Pathology Day virtual space on Gather.town will be similar to an ‘onsite’ conference\, where you can meet your colleagues\, friends\, and other attendees to strike up conversations just like you would at an in-person event. Further\, it allows attendees to view talks by visiting specific rooms\, and an interactive poster session that facilitates walking through a room\, visiting those of interest and asking questions directly to the presenter face to face. \nAll talks will be done through Zoom\, accessible through the Gather town platform or directly through provided links. Posters will need to be provided to organizers by May 24th in .jpeg or .png format. \n 
URL:https://scienceinvancouver.com/event/pathology-day-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210602T110000
DTEND;TZID=America/Vancouver:20210602T120000
DTSTAMP:20260408T134701
CREATED:20210528T200943Z
LAST-MODIFIED:20210528T200943Z
UID:16703-1622631600-1622635200@scienceinvancouver.com
SUMMARY:The Centre for Blood Research Virtual Seminar Series: Dr. Eun-Ju Lee
DESCRIPTION:Eun-Ju Lee\nAssistant Professor\, Weill Cornell Medical College\, Department of Medicine\, Division of Hematology \n“SARS-CoV-2 Vaccination and Immune Thrombocytopenia”\nCases of severe thrombocytopenia following SARS-CoV-2 vaccination in patients without previous immune thrombocytopenia (ITP) including an early fatality raised concern\, particularly among those with preexisting ITP\, regarding the safety of vaccination. We reviewed the Vaccine Adverse Events Reporting System (VAERS) to identify cases suspicious for de novo ITP (last access March 19\, 2021) and gathered data across several centers regarding adult patients with ITP who received a SARS-CoV2 vaccine. Our (yet unpublished) findings support that the majority of patients with ITP did well after SARS-CoV-2 vaccination.
URL:https://scienceinvancouver.com/event/the-centre-for-blood-research-virtual-seminar-series-dr-eun-ju-lee/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210602T110000
DTEND;TZID=America/Vancouver:20210602T120000
DTSTAMP:20260408T134701
CREATED:20210528T200943Z
LAST-MODIFIED:20210528T200943Z
UID:26396-1622631600-1622635200@scienceinvancouver.com
SUMMARY:The Centre for Blood Research Virtual Seminar Series: Dr. Eun-Ju Lee
DESCRIPTION:Eun-Ju Lee\nAssistant Professor\, Weill Cornell Medical College\, Department of Medicine\, Division of Hematology \n“SARS-CoV-2 Vaccination and Immune Thrombocytopenia”\nCases of severe thrombocytopenia following SARS-CoV-2 vaccination in patients without previous immune thrombocytopenia (ITP) including an early fatality raised concern\, particularly among those with preexisting ITP\, regarding the safety of vaccination. We reviewed the Vaccine Adverse Events Reporting System (VAERS) to identify cases suspicious for de novo ITP (last access March 19\, 2021) and gathered data across several centers regarding adult patients with ITP who received a SARS-CoV2 vaccine. Our (yet unpublished) findings support that the majority of patients with ITP did well after SARS-CoV-2 vaccination.
URL:https://scienceinvancouver.com/event/the-centre-for-blood-research-virtual-seminar-series-dr-eun-ju-lee-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210602T110000
DTEND;TZID=America/Vancouver:20210602T120000
DTSTAMP:20260408T134701
CREATED:20210528T200943Z
LAST-MODIFIED:20210528T200943Z
UID:28011-1622631600-1622635200@scienceinvancouver.com
SUMMARY:The Centre for Blood Research Virtual Seminar Series: Dr. Eun-Ju Lee
DESCRIPTION:Eun-Ju Lee\nAssistant Professor\, Weill Cornell Medical College\, Department of Medicine\, Division of Hematology \n“SARS-CoV-2 Vaccination and Immune Thrombocytopenia”\nCases of severe thrombocytopenia following SARS-CoV-2 vaccination in patients without previous immune thrombocytopenia (ITP) including an early fatality raised concern\, particularly among those with preexisting ITP\, regarding the safety of vaccination. We reviewed the Vaccine Adverse Events Reporting System (VAERS) to identify cases suspicious for de novo ITP (last access March 19\, 2021) and gathered data across several centers regarding adult patients with ITP who received a SARS-CoV2 vaccine. Our (yet unpublished) findings support that the majority of patients with ITP did well after SARS-CoV-2 vaccination.
URL:https://scienceinvancouver.com/event/the-centre-for-blood-research-virtual-seminar-series-dr-eun-ju-lee-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210602T110000
DTEND;TZID=America/Vancouver:20210602T120000
DTSTAMP:20260408T134701
CREATED:20210528T200943Z
LAST-MODIFIED:20210528T200943Z
UID:31094-1622631600-1622635200@scienceinvancouver.com
SUMMARY:The Centre for Blood Research Virtual Seminar Series: Dr. Eun-Ju Lee
DESCRIPTION:Eun-Ju Lee\nAssistant Professor\, Weill Cornell Medical College\, Department of Medicine\, Division of Hematology \n“SARS-CoV-2 Vaccination and Immune Thrombocytopenia”\nCases of severe thrombocytopenia following SARS-CoV-2 vaccination in patients without previous immune thrombocytopenia (ITP) including an early fatality raised concern\, particularly among those with preexisting ITP\, regarding the safety of vaccination. We reviewed the Vaccine Adverse Events Reporting System (VAERS) to identify cases suspicious for de novo ITP (last access March 19\, 2021) and gathered data across several centers regarding adult patients with ITP who received a SARS-CoV2 vaccine. Our (yet unpublished) findings support that the majority of patients with ITP did well after SARS-CoV-2 vaccination.
URL:https://scienceinvancouver.com/event/the-centre-for-blood-research-virtual-seminar-series-dr-eun-ju-lee-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210602T110000
DTEND;TZID=America/Vancouver:20210602T120000
DTSTAMP:20260408T134701
CREATED:20210528T200943Z
LAST-MODIFIED:20210528T200943Z
UID:32554-1622631600-1622635200@scienceinvancouver.com
SUMMARY:The Centre for Blood Research Virtual Seminar Series: Dr. Eun-Ju Lee
DESCRIPTION:Eun-Ju Lee\nAssistant Professor\, Weill Cornell Medical College\, Department of Medicine\, Division of Hematology \n“SARS-CoV-2 Vaccination and Immune Thrombocytopenia”\nCases of severe thrombocytopenia following SARS-CoV-2 vaccination in patients without previous immune thrombocytopenia (ITP) including an early fatality raised concern\, particularly among those with preexisting ITP\, regarding the safety of vaccination. We reviewed the Vaccine Adverse Events Reporting System (VAERS) to identify cases suspicious for de novo ITP (last access March 19\, 2021) and gathered data across several centers regarding adult patients with ITP who received a SARS-CoV2 vaccine. Our (yet unpublished) findings support that the majority of patients with ITP did well after SARS-CoV-2 vaccination.
URL:https://scienceinvancouver.com/event/the-centre-for-blood-research-virtual-seminar-series-dr-eun-ju-lee-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210602T120000
DTEND;TZID=America/Vancouver:20210602T130000
DTSTAMP:20260408T134701
CREATED:20210510T155652Z
LAST-MODIFIED:20210510T155817Z
UID:16459-1622635200-1622638800@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Nathaniel Hawkins
DESCRIPTION:Nathaniel Hawkins\, MBChB\, MD\, MPH\nScientist\, CHÉOS\nClinical Assistant Professor\, Division of Cardiology\, UBC \nClick here to register (required) \nUse of implantable cardioverter defibrillators following out-of-hospital cardiac arrest: a linked analysis of prospective registries in British Columbia \nIn randomized controlled trials of secondary prevention of sudden cardiac death\, implantable cardioverter defibrillators (ICDs) reduced the risk of all-cause and arrhythmic death. These studies enrolled patients with documented ventricular tachycardia (VT) or ventricular fibrillation (VF) and excluded those with reversible causes. Approximately half of patients with VF/VT out of hospital cardiac arrest surviving to discharge have reversible causes. Prior studies have suggested appropriate use of secondary prevention ICDs has been surprisingly low (7% to 34%)\, although these studies were conducted in the 1990s and early millennium\, and none excluded patients with reversible causes. We therefore examined the rate\, predictors and associated outcomes of ICD implant following OHCA in patients with shockable presenting rhythm and no reversible cause.
URL:https://scienceinvancouver.com/event/wip-seminar-dr-nathaniel-hawkins/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210602T120000
DTEND;TZID=America/Vancouver:20210602T130000
DTSTAMP:20260408T134701
CREATED:20210510T155652Z
LAST-MODIFIED:20210510T155652Z
UID:26383-1622635200-1622638800@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Nathaniel Hawkins
DESCRIPTION:Nathaniel Hawkins\, MBChB\, MD\, MPH\nScientist\, CHÉOS\nClinical Assistant Professor\, Division of Cardiology\, UBC \nClick here to register (required) \nUse of implantable cardioverter defibrillators following out-of-hospital cardiac arrest: a linked analysis of prospective registries in British Columbia \nIn randomized controlled trials of secondary prevention of sudden cardiac death\, implantable cardioverter defibrillators (ICDs) reduced the risk of all-cause and arrhythmic death. These studies enrolled patients with documented ventricular tachycardia (VT) or ventricular fibrillation (VF) and excluded those with reversible causes. Approximately half of patients with VF/VT out of hospital cardiac arrest surviving to discharge have reversible causes. Prior studies have suggested appropriate use of secondary prevention ICDs has been surprisingly low (7% to 34%)\, although these studies were conducted in the 1990s and early millennium\, and none excluded patients with reversible causes. We therefore examined the rate\, predictors and associated outcomes of ICD implant following OHCA in patients with shockable presenting rhythm and no reversible cause.
URL:https://scienceinvancouver.com/event/wip-seminar-dr-nathaniel-hawkins-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210602T120000
DTEND;TZID=America/Vancouver:20210602T130000
DTSTAMP:20260408T134701
CREATED:20210510T155652Z
LAST-MODIFIED:20210510T155652Z
UID:27998-1622635200-1622638800@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Nathaniel Hawkins
DESCRIPTION:Nathaniel Hawkins\, MBChB\, MD\, MPH\nScientist\, CHÉOS\nClinical Assistant Professor\, Division of Cardiology\, UBC \nClick here to register (required) \nUse of implantable cardioverter defibrillators following out-of-hospital cardiac arrest: a linked analysis of prospective registries in British Columbia \nIn randomized controlled trials of secondary prevention of sudden cardiac death\, implantable cardioverter defibrillators (ICDs) reduced the risk of all-cause and arrhythmic death. These studies enrolled patients with documented ventricular tachycardia (VT) or ventricular fibrillation (VF) and excluded those with reversible causes. Approximately half of patients with VF/VT out of hospital cardiac arrest surviving to discharge have reversible causes. Prior studies have suggested appropriate use of secondary prevention ICDs has been surprisingly low (7% to 34%)\, although these studies were conducted in the 1990s and early millennium\, and none excluded patients with reversible causes. We therefore examined the rate\, predictors and associated outcomes of ICD implant following OHCA in patients with shockable presenting rhythm and no reversible cause.
URL:https://scienceinvancouver.com/event/wip-seminar-dr-nathaniel-hawkins-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210602T120000
DTEND;TZID=America/Vancouver:20210602T130000
DTSTAMP:20260408T134701
CREATED:20210510T155652Z
LAST-MODIFIED:20210510T155652Z
UID:31081-1622635200-1622638800@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Nathaniel Hawkins
DESCRIPTION:Nathaniel Hawkins\, MBChB\, MD\, MPH\nScientist\, CHÉOS\nClinical Assistant Professor\, Division of Cardiology\, UBC \nClick here to register (required) \nUse of implantable cardioverter defibrillators following out-of-hospital cardiac arrest: a linked analysis of prospective registries in British Columbia \nIn randomized controlled trials of secondary prevention of sudden cardiac death\, implantable cardioverter defibrillators (ICDs) reduced the risk of all-cause and arrhythmic death. These studies enrolled patients with documented ventricular tachycardia (VT) or ventricular fibrillation (VF) and excluded those with reversible causes. Approximately half of patients with VF/VT out of hospital cardiac arrest surviving to discharge have reversible causes. Prior studies have suggested appropriate use of secondary prevention ICDs has been surprisingly low (7% to 34%)\, although these studies were conducted in the 1990s and early millennium\, and none excluded patients with reversible causes. We therefore examined the rate\, predictors and associated outcomes of ICD implant following OHCA in patients with shockable presenting rhythm and no reversible cause.
URL:https://scienceinvancouver.com/event/wip-seminar-dr-nathaniel-hawkins-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210602T120000
DTEND;TZID=America/Vancouver:20210602T130000
DTSTAMP:20260408T134701
CREATED:20210510T155652Z
LAST-MODIFIED:20210510T155652Z
UID:32541-1622635200-1622638800@scienceinvancouver.com
SUMMARY:WiP Seminar: Dr. Nathaniel Hawkins
DESCRIPTION:Nathaniel Hawkins\, MBChB\, MD\, MPH\nScientist\, CHÉOS\nClinical Assistant Professor\, Division of Cardiology\, UBC \nClick here to register (required) \nUse of implantable cardioverter defibrillators following out-of-hospital cardiac arrest: a linked analysis of prospective registries in British Columbia \nIn randomized controlled trials of secondary prevention of sudden cardiac death\, implantable cardioverter defibrillators (ICDs) reduced the risk of all-cause and arrhythmic death. These studies enrolled patients with documented ventricular tachycardia (VT) or ventricular fibrillation (VF) and excluded those with reversible causes. Approximately half of patients with VF/VT out of hospital cardiac arrest surviving to discharge have reversible causes. Prior studies have suggested appropriate use of secondary prevention ICDs has been surprisingly low (7% to 34%)\, although these studies were conducted in the 1990s and early millennium\, and none excluded patients with reversible causes. We therefore examined the rate\, predictors and associated outcomes of ICD implant following OHCA in patients with shockable presenting rhythm and no reversible cause.
URL:https://scienceinvancouver.com/event/wip-seminar-dr-nathaniel-hawkins-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210604T110000
DTEND;TZID=America/Vancouver:20210604T120000
DTSTAMP:20260408T134701
CREATED:20210518T235943Z
LAST-MODIFIED:20210525T154458Z
UID:16564-1622804400-1622808000@scienceinvancouver.com
SUMMARY:The 17th D. Harold Copp Lecture
DESCRIPTION:Aging: a Gut Feeling\nLinda Partridge\, Founding Director of the Max Planck Institute for Biology of Aging\nThe loss of function and pathology caused by aging can be ameliorated by genetic and pharmacological interventions in laboratory animals. Inhibition of the mTOR network has evolutionarily conserved effects on lifespan and aging. We have found that the gut is a key target tissue for the mTORC1 inhibitor rapamycin\, with benefits to both the health of the gut itself and to lifespan. Intestinal health during aging is thus an important determinant of the health of the whole organism. \nZoom Registration Link
URL:https://scienceinvancouver.com/event/the-17th-d-harold-copp-lecture/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210604T110000
DTEND;TZID=America/Vancouver:20210604T120000
DTSTAMP:20260408T134701
CREATED:20210518T235943Z
LAST-MODIFIED:20210518T235943Z
UID:26392-1622804400-1622808000@scienceinvancouver.com
SUMMARY:The 17th D. Harold Copp Lecture
DESCRIPTION:Aging: a Gut Feeling\nLinda Partridge\, Founding Director of the Max Planck Institute for Biology of Aging\nThe loss of function and pathology caused by aging can be ameliorated by genetic and pharmacological interventions in laboratory animals. Inhibition of the mTOR network has evolutionarily conserved effects on lifespan and aging. We have found that the gut is a key target tissue for the mTORC1 inhibitor rapamycin\, with benefits to both the health of the gut itself and to lifespan. Intestinal health during aging is thus an important determinant of the health of the whole organism. \nZoom Registration Link
URL:https://scienceinvancouver.com/event/the-17th-d-harold-copp-lecture-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210604T110000
DTEND;TZID=America/Vancouver:20210604T120000
DTSTAMP:20260408T134701
CREATED:20210518T235943Z
LAST-MODIFIED:20210518T235943Z
UID:28007-1622804400-1622808000@scienceinvancouver.com
SUMMARY:The 17th D. Harold Copp Lecture
DESCRIPTION:Aging: a Gut Feeling\nLinda Partridge\, Founding Director of the Max Planck Institute for Biology of Aging\nThe loss of function and pathology caused by aging can be ameliorated by genetic and pharmacological interventions in laboratory animals. Inhibition of the mTOR network has evolutionarily conserved effects on lifespan and aging. We have found that the gut is a key target tissue for the mTORC1 inhibitor rapamycin\, with benefits to both the health of the gut itself and to lifespan. Intestinal health during aging is thus an important determinant of the health of the whole organism. \nZoom Registration Link
URL:https://scienceinvancouver.com/event/the-17th-d-harold-copp-lecture-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210604T110000
DTEND;TZID=America/Vancouver:20210604T120000
DTSTAMP:20260408T134701
CREATED:20210518T235943Z
LAST-MODIFIED:20210518T235943Z
UID:31090-1622804400-1622808000@scienceinvancouver.com
SUMMARY:The 17th D. Harold Copp Lecture
DESCRIPTION:Aging: a Gut Feeling\nLinda Partridge\, Founding Director of the Max Planck Institute for Biology of Aging\nThe loss of function and pathology caused by aging can be ameliorated by genetic and pharmacological interventions in laboratory animals. Inhibition of the mTOR network has evolutionarily conserved effects on lifespan and aging. We have found that the gut is a key target tissue for the mTORC1 inhibitor rapamycin\, with benefits to both the health of the gut itself and to lifespan. Intestinal health during aging is thus an important determinant of the health of the whole organism. \nZoom Registration Link
URL:https://scienceinvancouver.com/event/the-17th-d-harold-copp-lecture-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210604T110000
DTEND;TZID=America/Vancouver:20210604T120000
DTSTAMP:20260408T134701
CREATED:20210518T235943Z
LAST-MODIFIED:20210518T235943Z
UID:32550-1622804400-1622808000@scienceinvancouver.com
SUMMARY:The 17th D. Harold Copp Lecture
DESCRIPTION:Aging: a Gut Feeling\nLinda Partridge\, Founding Director of the Max Planck Institute for Biology of Aging\nThe loss of function and pathology caused by aging can be ameliorated by genetic and pharmacological interventions in laboratory animals. Inhibition of the mTOR network has evolutionarily conserved effects on lifespan and aging. We have found that the gut is a key target tissue for the mTORC1 inhibitor rapamycin\, with benefits to both the health of the gut itself and to lifespan. Intestinal health during aging is thus an important determinant of the health of the whole organism. \nZoom Registration Link
URL:https://scienceinvancouver.com/event/the-17th-d-harold-copp-lecture-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210608T090000
DTEND;TZID=America/Vancouver:20210609T130000
DTSTAMP:20260408T134701
CREATED:20210325T164824Z
LAST-MODIFIED:20210325T164824Z
UID:15780-1623142800-1623243600@scienceinvancouver.com
SUMMARY:SBME Annual Symposium 2021
DESCRIPTION:Mark your calendars! The SBME Annual Symposium will take place on June 8-9\, 2021\, 9:00am-1:00pm (PST) both days. \nThe Symposium will be a virtual event this year and showcase industry panels\, research presentations\, poster sessions\, and keynote talks from Dr. Ali Khademhosseini and Dr. Jennifer Elisseeff. Check out their bios below\, and stay tuned for more event details to come. \nKeynote Speakers\n \n  \nDr. Ali Khademhosseini\nCEO and Founding Director\, Terasaki Institute for Biomedical Innovation \nAli Khademhosseini is the CEO and Founding Director at the Terasaki Institute for Biomedical Innovation. Previously\, he was a Professor of Bioengineering\, Chemical Engineering\, and Radiology at the University of California-Los Angeles (UCLA). He joined UCLA as the Levi Knight Chair in November 2017 from Harvard University where he was Professor at Harvard Medical School and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST)\, Brigham and Women’s Hospital (BWH)\, and associate faculty at the Wyss Institute for Biologically Inspired Engineering. Dr. Khademhosseini is an Associate Editor for ACS Nano. \n  \n  \n \n  \nDr. Jennifer Elisseeff\nProfessor and Director\, Translational Tissue Engineering Center\nWilmer Eye Institute and Departments of Biomedical Engineering\, Orthopedic Surgery\, Chemical and Biological Engineering\, and Materials Science and Engineering;\nJohns Hopkins University \nDr. Elisseeff is the Morton Goldberg Professor and Director of the Translational Tissue Engineering Center at Johns Hopkins Department of Biomedical Engineering and the Wilmer Eye Institute\, with appointments in Chemical and Biological Engineering\, Materials Science\, and Orthopedic Surgery. She was elected a Fellow of the American Institute of Medical and Biological Engineering\, the National Academy of Inventors\, and a Young Global Leader by World Economic Forum.
URL:https://scienceinvancouver.com/event/sbme-annual-symposium-2021/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/SMBE-Symposium.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210608T090000
DTEND;TZID=America/Vancouver:20210609T130000
DTSTAMP:20260408T134701
CREATED:20210325T164824Z
LAST-MODIFIED:20210325T164824Z
UID:26366-1623142800-1623243600@scienceinvancouver.com
SUMMARY:SBME Annual Symposium 2021
DESCRIPTION:Mark your calendars! The SBME Annual Symposium will take place on June 8-9\, 2021\, 9:00am-1:00pm (PST) both days. \nThe Symposium will be a virtual event this year and showcase industry panels\, research presentations\, poster sessions\, and keynote talks from Dr. Ali Khademhosseini and Dr. Jennifer Elisseeff. Check out their bios below\, and stay tuned for more event details to come. \nKeynote Speakers\n \n  \nDr. Ali Khademhosseini\nCEO and Founding Director\, Terasaki Institute for Biomedical Innovation \nAli Khademhosseini is the CEO and Founding Director at the Terasaki Institute for Biomedical Innovation. Previously\, he was a Professor of Bioengineering\, Chemical Engineering\, and Radiology at the University of California-Los Angeles (UCLA). He joined UCLA as the Levi Knight Chair in November 2017 from Harvard University where he was Professor at Harvard Medical School and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST)\, Brigham and Women’s Hospital (BWH)\, and associate faculty at the Wyss Institute for Biologically Inspired Engineering. Dr. Khademhosseini is an Associate Editor for ACS Nano. \n  \n  \n \n  \nDr. Jennifer Elisseeff\nProfessor and Director\, Translational Tissue Engineering Center\nWilmer Eye Institute and Departments of Biomedical Engineering\, Orthopedic Surgery\, Chemical and Biological Engineering\, and Materials Science and Engineering;\nJohns Hopkins University \nDr. Elisseeff is the Morton Goldberg Professor and Director of the Translational Tissue Engineering Center at Johns Hopkins Department of Biomedical Engineering and the Wilmer Eye Institute\, with appointments in Chemical and Biological Engineering\, Materials Science\, and Orthopedic Surgery. She was elected a Fellow of the American Institute of Medical and Biological Engineering\, the National Academy of Inventors\, and a Young Global Leader by World Economic Forum.
URL:https://scienceinvancouver.com/event/sbme-annual-symposium-2021-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/SMBE-Symposium.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210608T090000
DTEND;TZID=America/Vancouver:20210609T130000
DTSTAMP:20260408T134701
CREATED:20210325T164824Z
LAST-MODIFIED:20210325T164824Z
UID:27981-1623142800-1623243600@scienceinvancouver.com
SUMMARY:SBME Annual Symposium 2021
DESCRIPTION:Mark your calendars! The SBME Annual Symposium will take place on June 8-9\, 2021\, 9:00am-1:00pm (PST) both days. \nThe Symposium will be a virtual event this year and showcase industry panels\, research presentations\, poster sessions\, and keynote talks from Dr. Ali Khademhosseini and Dr. Jennifer Elisseeff. Check out their bios below\, and stay tuned for more event details to come. \nKeynote Speakers\n \n  \nDr. Ali Khademhosseini\nCEO and Founding Director\, Terasaki Institute for Biomedical Innovation \nAli Khademhosseini is the CEO and Founding Director at the Terasaki Institute for Biomedical Innovation. Previously\, he was a Professor of Bioengineering\, Chemical Engineering\, and Radiology at the University of California-Los Angeles (UCLA). He joined UCLA as the Levi Knight Chair in November 2017 from Harvard University where he was Professor at Harvard Medical School and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST)\, Brigham and Women’s Hospital (BWH)\, and associate faculty at the Wyss Institute for Biologically Inspired Engineering. Dr. Khademhosseini is an Associate Editor for ACS Nano. \n  \n  \n \n  \nDr. Jennifer Elisseeff\nProfessor and Director\, Translational Tissue Engineering Center\nWilmer Eye Institute and Departments of Biomedical Engineering\, Orthopedic Surgery\, Chemical and Biological Engineering\, and Materials Science and Engineering;\nJohns Hopkins University \nDr. Elisseeff is the Morton Goldberg Professor and Director of the Translational Tissue Engineering Center at Johns Hopkins Department of Biomedical Engineering and the Wilmer Eye Institute\, with appointments in Chemical and Biological Engineering\, Materials Science\, and Orthopedic Surgery. She was elected a Fellow of the American Institute of Medical and Biological Engineering\, the National Academy of Inventors\, and a Young Global Leader by World Economic Forum.
URL:https://scienceinvancouver.com/event/sbme-annual-symposium-2021-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/SMBE-Symposium.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210608T090000
DTEND;TZID=America/Vancouver:20210609T130000
DTSTAMP:20260408T134701
CREATED:20210325T164824Z
LAST-MODIFIED:20210325T164824Z
UID:31064-1623142800-1623243600@scienceinvancouver.com
SUMMARY:SBME Annual Symposium 2021
DESCRIPTION:Mark your calendars! The SBME Annual Symposium will take place on June 8-9\, 2021\, 9:00am-1:00pm (PST) both days. \nThe Symposium will be a virtual event this year and showcase industry panels\, research presentations\, poster sessions\, and keynote talks from Dr. Ali Khademhosseini and Dr. Jennifer Elisseeff. Check out their bios below\, and stay tuned for more event details to come. \nKeynote Speakers\n \n  \nDr. Ali Khademhosseini\nCEO and Founding Director\, Terasaki Institute for Biomedical Innovation \nAli Khademhosseini is the CEO and Founding Director at the Terasaki Institute for Biomedical Innovation. Previously\, he was a Professor of Bioengineering\, Chemical Engineering\, and Radiology at the University of California-Los Angeles (UCLA). He joined UCLA as the Levi Knight Chair in November 2017 from Harvard University where he was Professor at Harvard Medical School and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST)\, Brigham and Women’s Hospital (BWH)\, and associate faculty at the Wyss Institute for Biologically Inspired Engineering. Dr. Khademhosseini is an Associate Editor for ACS Nano. \n  \n  \n \n  \nDr. Jennifer Elisseeff\nProfessor and Director\, Translational Tissue Engineering Center\nWilmer Eye Institute and Departments of Biomedical Engineering\, Orthopedic Surgery\, Chemical and Biological Engineering\, and Materials Science and Engineering;\nJohns Hopkins University \nDr. Elisseeff is the Morton Goldberg Professor and Director of the Translational Tissue Engineering Center at Johns Hopkins Department of Biomedical Engineering and the Wilmer Eye Institute\, with appointments in Chemical and Biological Engineering\, Materials Science\, and Orthopedic Surgery. She was elected a Fellow of the American Institute of Medical and Biological Engineering\, the National Academy of Inventors\, and a Young Global Leader by World Economic Forum.
URL:https://scienceinvancouver.com/event/sbme-annual-symposium-2021-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/SMBE-Symposium.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210608T090000
DTEND;TZID=America/Vancouver:20210609T130000
DTSTAMP:20260408T134701
CREATED:20210325T164824Z
LAST-MODIFIED:20210325T164824Z
UID:32524-1623142800-1623243600@scienceinvancouver.com
SUMMARY:SBME Annual Symposium 2021
DESCRIPTION:Mark your calendars! The SBME Annual Symposium will take place on June 8-9\, 2021\, 9:00am-1:00pm (PST) both days. \nThe Symposium will be a virtual event this year and showcase industry panels\, research presentations\, poster sessions\, and keynote talks from Dr. Ali Khademhosseini and Dr. Jennifer Elisseeff. Check out their bios below\, and stay tuned for more event details to come. \nKeynote Speakers\n \n  \nDr. Ali Khademhosseini\nCEO and Founding Director\, Terasaki Institute for Biomedical Innovation \nAli Khademhosseini is the CEO and Founding Director at the Terasaki Institute for Biomedical Innovation. Previously\, he was a Professor of Bioengineering\, Chemical Engineering\, and Radiology at the University of California-Los Angeles (UCLA). He joined UCLA as the Levi Knight Chair in November 2017 from Harvard University where he was Professor at Harvard Medical School and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST)\, Brigham and Women’s Hospital (BWH)\, and associate faculty at the Wyss Institute for Biologically Inspired Engineering. Dr. Khademhosseini is an Associate Editor for ACS Nano. \n  \n  \n \n  \nDr. Jennifer Elisseeff\nProfessor and Director\, Translational Tissue Engineering Center\nWilmer Eye Institute and Departments of Biomedical Engineering\, Orthopedic Surgery\, Chemical and Biological Engineering\, and Materials Science and Engineering;\nJohns Hopkins University \nDr. Elisseeff is the Morton Goldberg Professor and Director of the Translational Tissue Engineering Center at Johns Hopkins Department of Biomedical Engineering and the Wilmer Eye Institute\, with appointments in Chemical and Biological Engineering\, Materials Science\, and Orthopedic Surgery. She was elected a Fellow of the American Institute of Medical and Biological Engineering\, the National Academy of Inventors\, and a Young Global Leader by World Economic Forum.
URL:https://scienceinvancouver.com/event/sbme-annual-symposium-2021-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/SMBE-Symposium.png
END:VEVENT
END:VCALENDAR